期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

小剂量阿司匹林预防子痫前期 被引量：9

原文传递
导出
摘要 近年来，子痫前期研究的热点集中于预测和预防。循证医学证据表明，小剂量阿司匹林对子痫前期有一定的预防作用。美国、英国、加拿大、世界卫生组织已将小剂量阿司匹林用于高危孕妇的子痫前期预防写入指南。如果能够对子痫前期的发病或者进展进行有效的预防，无疑是围产领域的重大突破。
作者 朱毓纯 杨慧霞
机构地区 北京大学第一医院妇产科
出处 《中华围产医学杂志》 CAS CSCD 2015年第1期3-4,共2页 Chinese Journal of Perinatal Medicine
关键词 小剂量阿司匹林 子痫前期 预防作用 循证医学证据 世界卫生组织 前期预防 高危孕妇 加拿大
分类号 R714.244 [医药卫生—妇产科学]
  • 相关文献

参考文献11

  • 1朱毓纯,杨慧霞.子痫前期预测和预防的研究进展[J].中华围产医学杂志,2013,16(1):39-41. 被引量：19
  • 2Magee LA, Helewa M, Moutquin JM, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaecol Can, 2008, 30(3 Suppl): S1-48.
  • 3Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341: c2207.
  • 4Duley L, Henderson-Smart D J, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications[CD]. Cochrane Database Syst Rev, 2007, (2): CD004659.
  • 5American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on hypertension in pregnancy[J]. Obstet Gynecol, 2013, 122(5): 1122-1131.
  • 6Henderson JT, Whitlock EP, O'Conner E, et al. Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force [Internet] [J/OL]. Rockville (MD): Agency for Healtheare Research and Quality (US).2014. Report No.: 14-05207-EF-1.
  • 7LeFevre ML. Low dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement[J]. Ann Intern Med, 2014, 161(11): 819-826.
  • 8Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units[J]. N Engl J Med, 1993, 329(17): 1213-1218.
  • 9Caritis S, Sibai B, Hauth J, et al. Low dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units[J]. N Engl J Med, 1998, 338(11): 701-705.
  • 10McParland P, Pearce JM, Chamberlain GV. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hvoertension[J]. Lancet. 1990. 335(8705): 1552- 1555.

二级参考文献23

  • 1Papageorghiou AT,Yu CK,Bindra R. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation[J].Ultrasound in Obstetrics and Gynecology,2001.441-449.
  • 2LevineRJ,Maynard SE,Qian C. Circulating angiogenic factors and the risk of preeclampsia[J].New England Journal of Medicine,2004.672-683.
  • 3DiLorenzoG,Ceccarello M,Cecotti V. First trimester maternal serum PIGF,free β-hCG,PAPP-A,PP-13,uterine artery Doppler and maternal history for the prediction of preeclampsia[J].Placenta,2012.495-501.
  • 4Poon LC,Akolekar R,Lachmann R. Hypertensive disorders in pregnancy:screening by biophysical and biochemical markers at 11-13 weeks[J].Ultrasound in Obstetrics and Gynecology,2010.662-670.
  • 5Poon LC,Kametas NA,Maiz N. First-trimester prediction of hypertensive disorders in pregnancy[J].Hypertension,2009.812-818.
  • 6Akolekar R,Syngelaki A,Sarquis R. Prediction of early,intermediate and late pre-eclampsia from maternal factors,biophysical and biochemical markers at 11-13 weeks[J].Prenatal Diagnosis,2011.66-74.
  • 7Vatten LJ,Eskild A,Nilsen TI. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia[J].American Journal of Obstetrics and Gynecology,2007.239,e1-6.
  • 8Rana S,Karumanchi SA,Levine RJ. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia[J].Hypertension,2007,(1):137-142.doi:10.1161/HYPERTENSIONAHA.107.087700.
  • 9Cowans NJ,Stamatopoulou A,Spencer K. First trimester maternal serum placental growth factor in trisomy 21pregnancies[J].Prenatal Diagnosis,2010.449-453.
  • 10Verlohren S,Herraiz I,Lapaire O. Risk stratification of hypertensive pregnancy disorders[J].European Journal of Obstetrics & Gynecology and Reproductive Biology,2012.14-17.

共引文献316

同被引文献91

  • 1尹松梅,李益清,谢双锋,马丽萍,吴裕丹,聂大年,冯坚红,徐立卓.妊娠高血压综合征及妊娠期糖尿病孕妇血小板功能状态的研究[J].中华妇产科杂志,2005,40(1):25-28. 被引量：26
  • 2吕秀翠,刘群英,高峰玉.低分子肝素结合常规疗法治疗重度子癎前期的疗效探讨[J].中国实用妇科与产科杂志,2006,22(7):515-518. 被引量：20
  • 3董熙萍,徐永萍.低分子肝素对胎儿生长受限的治疗作用[J].实用妇产科杂志,2006,22(9):531-533. 被引量：8
  • 4American College of Obstetricians and Gynecologists, Task Force on Hypertension in pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy[J]. Obstet Gynecol,2013, 122(5): 1122-1131.
  • 5D i a g nos t i k un d The rap i e h y per ten s i v e r Schwangerschaftserkrankungen[EB/OL].(20 13-12)[20 15-03- o 1].http://www.awmf.org/uploads/tx_szleitiinien/015-0 181_ S 1_ Diagnostik _ Therapie _ hypertensi ver _ Schwangerschaftserkranku ngen_20 14-0 I.pdf.
  • 6Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014,36(5):416- 441.
  • 7Royal College of Obstetricians & Gynaecologists. Severe pre?eclampsia/eclampsia, management (Green-top Guideline No. 10A)[EB/OL]. (2006-03-01)[2015-03-0 I]. https:l/www.rcog. org. uk/enl guidelines-research-services/ guidelinesl gtg I Oa/.
  • 8Lowe SA, Brown MA, Dekker GA, et al. Guideline for the management of hypertensive disorders of pregnancy 2008[J]. Aust N Z J Obstet Gynaecol,2009,49(3):242-246.
  • 9World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia[EBI OL]. (20 II )[20 15 -03 -0 I]. http://whqlibdoc . who. inti publications/201 119789241 548335 _eng.pdf?ua=l.
  • 10U.S.Food and Drug Administration. FDA Drug Safety Communication. FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies[EB/OL].(2013-05-30)[20 15-03-0 I]. http:// www.fda.gov/downloads/DrugslDrugSafety/UCM353335.pdf.

引证文献9

二级引证文献75

中华围产医学杂志
2015年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部